New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 28, 2014
14:25 EDTABT, ABT, ATRC, ATRC, BSX, BSX, EW, EW, MDT, MDT, STJ, STJ, VOLC, VOLCLeerink medical devices analyst holds an analyst/industry conference call
Medical Devices Analyst Antalffy, along with MEDACorp Specialist Arie Pieter Kappetein, MD, PhD and Bernhard Meier, MD, assess EU cardiology trends on an Analyst/Industry conference call to be held on July 31 at 3 pm.
News For ABT;ATRC;BSX;EW;MDT;STJ;VOLC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 23, 2015
16:33 EDTMDTMedtronic reports 5.1% passive stake in Intersect ENT
Subscribe for More Information
15:46 EDTMDTPiper Jaffray's medtech analysts hold an analyst/industry conference call
Subscribe for More Information
14:02 EDTBSXJPMorgan reports 5.7% passive stake in Boston Scientific
08:36 EDTMDTMedtronic receives FDA approval for for the Medtronic Enterra II System
Subscribe for More Information
January 22, 2015
07:31 EDTBSXBoston Scientific damages in case likely to be manageable, says Wells Fargo
Subscribe for More Information
05:47 EDTBSXStocks with implied volatility movement; BSX T
Stocks with implied volatility movement; Boston Scientific (BSX) 49, AT&T (T) 20 according to iVolatility.
January 21, 2015
18:06 EDTMDTS&P announces changes to the S&P 500, MidCap 400, SmallCap 600 indices
Subscribe for More Information
January 15, 2015
11:38 EDTATRCAtriCure management to meet with JMP Securities
Meeting to be held in San Diego on January 22 hosted by JMP Securities.
January 14, 2015
16:07 EDTATRC AtriCure names Douglas Seith as COO and Andy Wade as CFO
AtriCure, Inc. announced that Douglas Seith will assume the role of COO. Douglas Seith will now be responsible for all global commercial organizations as well as education and clinical science programs. The company also announced that Andy Wade has been promoted to senior VP and CFO.
09:03 EDTSTJSt. Jude Medical sees Q4 adjusted EPS within $1.02-$1.04 guidance range
Subscribe for More Information
09:02 EDTSTJSt. Jude Medical sees Q4 net sales approximately $1.439B, consensus $1.44B
Subscribe for More Information
09:01 EDTSTJSt. Jude Medical authorizes $500M share repurchase program
The company announced that its board of directors has authorized the repurchase of up to $500M of St. Jude Medical common stock. The repurchases will occur at such times and at such prices as the management of the company determines and may be effected through transactions in the open market, in privately negotiated transactions or otherwise. Any shares acquired in the $500M repurchase program will be available for general corporate purposes, including offsetting dilution associated with stock option and other equity-based employee benefit plans. The company had approximately 287 million shares of common stock outstanding as of Jan. 13, 2015.
January 13, 2015
10:00 EDTABTOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
05:57 EDTABTAbbott downgraded to Hold from Buy at Jefferies
Subscribe for More Information
January 12, 2015
13:02 EDTMDTMedtronic sees Coviden deal closing in last week of January, early February
Subscribe for More Information
08:38 EDTATRCAtriCure sees FY15 revenue $122.5M-$124.5M, consensus $122.95M
At current foreign exchange rates, this FY15 range reflects an estimated $1.6M adverse currency impact due to the weakening Euro against the U.S. Dollar. AtriCure sees FY15 adjusted EBITDA to be a loss in the range of ($7M)-($9M), as the company continues to make strategic investments to drive long-term growth.
08:36 EDTATRCAtriCure sees FY14 revenue $107.5M, consensus $105.72M
08:36 EDTATRCAtriCure sees Q4 revenue $29.5M, consensus $27.69M
Subscribe for More Information
07:17 EDTSTJJPMorgan to hold a conference
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use